VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 30, 2008) - Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI) (OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced research results which were presented by Dr. Ronnie Poon, from the Department of Surgery, University of Hong Kong at the American Association for Cancer Research (AACR) Annual Meeting. The data showed a strong anti-tumor effect in a preclinical model of liver cancer.
